XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows from Operating Activities:    
Net Income $ 78,554 $ 50,270
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation expense, intangible asset and other amortization 5,055 5,291
Stock-based compensation 7,021 5,983
Excess tax benefits from stock-based compensation (25,089)  
Amortization of deferred commissions 14,032 10,032
Payments of deferred commissions (11,761) (13,993)
Equity in earnings of equity method investments (295) (94)
Realized and unrealized gains on trading securities (1,712) (1,887)
Realized and unrealized (gains) losses on investments of consolidated sponsored investment products (1,247) 2,460
Sales (purchases) of trading securities, net 24,996 (1,163)
Purchase of investments by consolidated sponsored investment products, net (190,123) (53,531)
Sale of securities sold short by consolidated sponsored investment products, net 10,461  
Deferred income taxes 4,826 29,001
Changes in operating assets and liabilities:    
Cash pledged or on deposit of consolidated sponsored investment products (12,492)  
Accounts receivable, net and other assets (17,776) (10,083)
Other assets of consolidated sponsored investment products (481) (40,944)
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities 8,424 3,786
Liabilities of consolidated sponsored investment products 5,319 40,951
Net cash (used in) provided by operating activities (102,288) 26,079
Cash Flows from Investing Activities:    
Capital expenditures (1,814) (1,654)
Asset acquisitions (5,000) (3,364)
Change in cash and cash equivalents of consolidated sponsored investment products due to deconsolidation (366) (666)
Purchase of available-for-sale securities (260) (145)
Net cash used in investing activities (7,440) (5,829)
Cash Flows from Financing Activities:    
Contingent consideration paid for acquired investment management contracts 0 (420)
Proceeds from issuance of debt by consolidated sponsored investment products 1,200  
Dividends paid (4,104)  
Repurchase of common shares (26,257) (19,704)
Proceeds from exercise of stock options 660 478
Taxes paid related to net share settlement of restricted stock units (9,512) (7,493)
Proceeds from issuance of common stock, net of issuance costs 0 191,800
Payment on debt and deferred financing costs 0 (15,026)
Excess tax benefits from stock-based compensation 25,089  
Contributions of noncontrolling interests, net 24,871 11,396
Net cash provided by financing activities 11,947 161,031
Net (decrease) increase in cash and cash equivalents (97,781) 181,281
Cash and cash equivalents, beginning of period 271,545 63,446
Cash and Cash Equivalents, end of period 173,764 244,727
Non-Cash Financing Activities:    
(Decrease) increase to noncontrolling interest due to (deconsolidation) consolidation of sponsored investment products, net (44,613) 4,414
Dividend payable $ 4,229